Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_assertion type Assertion NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_head.
- NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_assertion description "[Studies presented or published during the European Society for Medical Oncology conference demonstrate that combining BRAF and MEK inhibitors improves progression-free and overall survival--and lowers the risk of resistance and toxicities--in patients with metastatic melanoma with BRAF V600E or V600K mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_provenance.
- NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_assertion evidence source_evidence_literature NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_provenance.
- NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_assertion SIO_000772 25477091 NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_provenance.
- NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_assertion wasDerivedFrom befree-2016 NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_provenance.
- NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_assertion wasGeneratedBy ECO_0000203 NP1245018.RA097oQ5iO27Uo9bwdSgEt5PV1h5QGEnbolHO5jai1OmE130_provenance.